Stemline Therapeutics Inc.

(STML) Trade

By |

Profile

Stemline Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, acquiring, developing and commercializing proprietary therapeutics that target both cancer stem cells, or CSCs, and tumor bulk.

Contact Information

Website: www.stemline.com
Email: info@stemline.com
Main Phone: +1 646 502-2311
Address: 750 Lexington Avenue
Address 2: 11th Floor
State: NY
City / Town: New York
Country: USA
Postal Code: 10022

Issuer Information

Exchange: NSC
CEO: Ivan Bergstein
Employees: 57
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 17.30 $ 0.30 (1.76%)
Last Price 17.30 Change $ 0.30 Change % 1.76 Tick N/A
Bid 13.10 Bid Size 2,000.00 Ask 18.70 Ask Size 500.00
Open 17.00 High 17.85 Low 16.95 Prev Close 17.00
Last Trade Volume 524,265 52 Wk Hi 20.55 52 Wk Low 10.20
Market Cap 535.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 30,975,042.00 EPS (TTM) -2.96 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 29
Number of Buys 0 7
Number of Sells 0 22
Net Activity 0 123202
Last 10 Buys Shares
Ivan Bergstein 1,000
Kenneth J. Zuerblis 1,000
Kenneth Hoberman 1,000
Kenneth J. Zuerblis 1,000
Kenneth J. Zuerblis 1,000
Kenneth J. Zuerblis 1,000
Kenneth J. Zuerblis 1,000
Kenneth J. Zuerblis 1,000
J. Kevin Buchi 1,000
Last 10 Sell Shares
Kenneth Hoberman 1,000
David G. Gionco 1,000
David G. Gionco 1,000
Ivan Bergstein 1,000
Kenneth Hoberman 1,000
Kenneth Hoberman 1,000
Ivan Bergstein 1,000
Ivan Bergstein 1,000
David G. Gionco 1,000
Kenneth Hoberman 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 41 41 41 41
Low Target Price Estimate 22 22 20 22
Mean Target Price Estimate 33.67 33.67 33 32.75
Standard Deviation 10.21 10.21 11.36 8.54
Date of Most Recent Estimate 05/29/18 05/29/18 05/09/18 06/12/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 4 4 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1